— Know what they know.
Not Investment Advice

CRYM OTC

Cryomass Technologies Inc.
1W: -99.5% 1M: -99.5% 3M: -99.5% YTD: -99.5% 1Y: -99.8% 3Y: -100.0% 5Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 48 · $47432 mcap · 177M float · 0.0093% daily turnover · Short 88% of daily vol

Cash Flow Trends

Operating Cash Flow
-$4M +20.2% ▲
Capital Expenditures
$74K +81.4% ▲
5Y CAGR: -30.5%
Free Cash Flow
-$4M +24.9% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$2M +47.6% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
— Operating Activities —
Net Income-$3M-$7M-$10M-$10M-$13M
Depreciation & Amort.$146K$678K$44K$157K$329K
Stock-Based Comp.$395K$1M$3M$603K$250K
Change in Working Capital$89K$933K-$1M$35K$847K
Other Non-Cash Items$628K$60K$3M$5M$8M
Operating Cash Flow-$2M-$4M-$6M-$5M-$4M
— Investing Activities —
Capital Expenditures-$38K$0-$225K-$400K-$25K
Acquisitions (Net)-$2M$0-$1M$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$1K-$693K-$2M-$619K-$49K
Investing Cash Flow-$2M-$693K-$3M-$1M-$74K
— Financing Activities —
Net Debt Issuance$0$663K$4M$2M$1M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing-$100K$0-$667K$0$149K
Financing Cash Flow$7M$1M$14M$2M$2M
Net Change in Cash$3M-$3M$5M-$4M-$2M
Cash End of Period$3M$330K$6M$2M$49K
Free Cash Flow-$2M-$4M-$6M-$5M-$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms